Naphthalene in the treatment of patients with atopic dermatitis.
Atopic dermatitis is a chronic relapsing inflammatory skin disease the incidence of which has been constantly growing in all age groups. Research into the use of naphthalene in the treatment of patients with psoriasis proved its anti-inflammatory and antiproliferative effects as well as a satisfactory remission for months in more than 70% of treated patients with psoriasis. The present study was undertaken to investigate the efficacy of naphthalene in the treatment of patients with atopic dermatitis. According to study results, naphthalene therapy proved efficacious and free from side effects in 20 atopic dermatitis patients.
Smeh-Skrbin
Ankica
A
Naftalan Special Hospital for Medical Rehabilitation, Omladinska 23a , HR-10310 Ivanić Grad, Croatia.
Dobrić
Ivan
I
Krnjević-Pezić
Gordana
G
Vrzogić
Pero
P
D000293:Adolescent; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D003876:Dermatitis, Atopic / Q000188:drug therapy* / Q000473:pathology; D003879:Dermatologic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009281:Naphthalenes / Q000627:therapeutic use*; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D003879:Dermatologic Agents; D009281:Naphthalenes; C031721:naphthalene